(RTTNews) - Bio-Techne Corp. (TECH) said that its RNAscope technology aids in the retrospective tissue diagnosis of covid-19 in cases with no previous testing for SARS-CoV-2. The company said it is ...
MINNEAPOLIS, April 8, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Advanced Cell Diagnostics (ACD), part of Bio-Techne's Spatial Biology Division, has surpassed ...
Direct detection of viral RNA in human or other animal cells by RNA in situ hybridization (ISH) technology is a powerful tool to establish the etiology and pathogenesis of viral disease. Nucleic ...
Reveal Biosciences, LLC, a leading preclinical services laboratory for advanced tissue technologies, is pleased to announce the availability of Advanced Cell Diagnostics' (ACD) RNAscope® in situ ...
The RNAscope in situ hybridization (ISH) technology is a powerful method for detecting gene expression with spatial and morphological tissue context. In this webinar, we will focus on an Integrated Co ...
MINNEAPOLIS, March 24, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced further advancements in its ongoing strategy to bring translational discoveries to patient care by ...
Bio-Techne Corporation today announced that Advanced Cell Diagnostics (ACD), part of Bio-Techne's Spatial Biology Division, has surpassed 10,000 peer-reviewed publications referencing the use and ...
(RTTNews) - Bio-Techne Corp. (TECH) said that its RNAscope technology aids in the retrospective tissue diagnosis of covid-19 in cases with no previous testing for SARS-CoV-2. The company said it is ...
Enabling Bio-Techne's gold-standard RNAscope ISH technology with Imaging Mass Cytometry detection to accelerate multiomic interrogation of health and disease. "Multiomic spatial imaging using the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback